rs67967266
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002156.5(HSPD1):c.551A>G(p.Asn184Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000546 in 1,613,192 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002156.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HSPD1 | NM_002156.5 | c.551A>G | p.Asn184Ser | missense_variant | 5/12 | ENST00000388968.8 | NP_002147.2 | |
HSPD1 | NM_199440.2 | c.551A>G | p.Asn184Ser | missense_variant | 5/12 | NP_955472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HSPD1 | ENST00000388968.8 | c.551A>G | p.Asn184Ser | missense_variant | 5/12 | 1 | NM_002156.5 | ENSP00000373620.3 |
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152240Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000469 AC: 118AN: 251386Hom.: 1 AF XY: 0.000500 AC XY: 68AN XY: 135888
GnomAD4 exome AF: 0.000568 AC: 830AN: 1460952Hom.: 2 Cov.: 29 AF XY: 0.000561 AC XY: 408AN XY: 726862
GnomAD4 genome AF: 0.000328 AC: 50AN: 152240Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74380
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia Uncertain:2
Uncertain significance, criteria provided, single submitter | research | Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde | Mar 07, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 01, 2020 | - - |
Spastic paraplegia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 184 of the HSPD1 protein (p.Asn184Ser). This variant is present in population databases (rs67967266, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with clinical features of hereditary spastic paraplegia (PMID: 28832565). ClinVar contains an entry for this variant (Variation ID: 424666). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HSPD1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect HSPD1 function (PMID: 27630992). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at